Class 2 Medicines Recall Cold & Flu Relief Capsules (GSL) – Various Liveries, Wrafton Laboratories Limited (trading as Perrigo), EL (21)A/28
Perrigo are recalling the above batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products as noted below.
MDR Number MDR 055-11/21
Company name Wrafton Laboratories Limited (trading as Perrigo)
Product descriptions
- Cold & Flu Relief Capsules (GSL) – Various Liveries PL 12063/0003
- Wilko Non-Drowsy Decongestant with Paracetamol PL 12063/0003
- Spar Cold Relief Capsules PL 12063/0003
- Essential Waitrose Cold & Flu Relief Capsules PL 12063/0003
- Aldi Health Essentials Cold Relief Capsules PL 12063/0003
- ASDA Cold Relief Capsules PL 12063/0003
- Superdrug Cold Relief Capsules PL 12063/0003
- Superdrug Non-Drowsy Decongestant with Paracetamol PL 12063/0003
- Sainsbury’s Healthcare Cold Relief Capsules PL 12063/0003
- Sainsbury’s Healthcare Sinus Dual Relief Capsules PL 12063/0003
- Lloyds Cold Relief Capsules PL 12063/0003
- WM Morrison Cold Relief Capsules PL 12063/0003
- Boots Cold & Flu Relief Capsules PL 12063/0003
- Boots Blocked Nose & Headache Relief Capsules PL 12063/0003
- Tesco Cold Relief Capsules PL 12063/0003
- Galpharm Cold Relief Capsules PL 12063/0003
Details of the affected batches
These can be found in the Recall document: Class 2 Medicines Recall EL (21)A/28
Brief description of problem
Perrigo are recalling the above batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products as noted above. The leaflet and carton incorrectly states that for Adults, the elderly and children 12 years and over, the dose should be 2 capsules every 4 to 6 hours as required, up to a maximum of 12 capsules in any 24 hour period. The leaflet and carton dosage instructions are those which were in use prior to the paediatric paracetamol posology update implemented by the MHRA.
As each capsule contains 300mg of paracetamol, 12 capsules would equate to 3.6g/day. This exceeds the MHRA recommended maximum dose for 12-15 year old’s, which is 3g/day.
The correct posology instructions should state the following:
Adults and children 16 years and over: 2 capsules every 4 to 6 hours as required, up to a maximum of 12 capsules (6 doses) in any 24 hour period.
Children aged 12 to 15 years: 2 capsules every 4 to 6 hours as required, up to a maximum of 8 capsules (4 doses) in any 24 hour period.
This product is only sold from various retail stores directly and impacts all products that share the PL number, but packaged in different liveries. If you have any concerns, please contact Perrigo using the details below.
This recall is not directed to patient level due to the safety assessment on the short-term use of this product by children aged 12 to 15 years.
Advice to Healthcare Professionals
- Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
- Any suspected side effects should be reported via the Yellow Card scheme
Advice for patients and consumers
- Please refer to the correct dosage instructions listed above for Children aged 12 to 15 years.
- If you experience any side-effects, or have any questions or concerns about your health, speak to your doctor or pharmacist.
- Report any suspected side effects via the Yellow Card scheme
Company contacts for further information
For more information, please contact: Perrigo Customer Services Team
Tel: 0203 598 9603 Email: UKLOCustomerService@perrigo.com
For stock control queries, please contact: Perrigo Service Team
Tel: 01226 704711 Email: customerservice@perrigouk.com
To access the full recall: Class 2 Medicines Recall EL (21)A/28